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Cortical interneurons represent 20% of the cells in the cortex. These cells are local
inhibitory neurons whose function is to modulate the firing activities of the excitatory
projection neurons. Cortical interneuron dysfunction is believed to lead to runaway
excitation underlying (or implicated in) seizure-based diseases, such as epilepsy, autism,
and schizophrenia. The complex development of this cell type and the intricacies involved
in defining the relative subtypes are being increasingly well defined. This has led to
exciting experimental cell therapy in model organisms, whereby fetal-derived interneuron
precursors can reverse seizure severity and reduce mortality in adult epileptic rodents.
These proof-of-principle studies raise hope for potential interneuron-based transplantation
therapies for treating epilepsy. On the other hand, cortical neurons generated from patient
iPSCs serve as a valuable tool to explore genetic influences of interneuron development
and function. This is a fundamental step in enhancing our understanding of the molecular
basis of neuropsychiatric illnesses and the development of targeted treatments. Protocols
are currently being developed for inducing cortical interneuron subtypes from mouse and
human pluripotent stem cells. This review sets out to summarize the progress made in
cortical interneuron development, fetal tissue transplantation and the recent advance in
stem cell differentiation toward interneurons.
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INTRODUCTION
The complex circuitries of the cerebral cortex comprise net-
works produced by two major neuronal cell types: the excitatory
glutamatergic projection neurons (Pyramidal cells) and gamma-
aminobutyric containing (GABAergic) interneurons. Pyramidal
neurons are the primary neural cells that specialize in transmit-
ting information between different cortical regions and to other
regions of the brain. Interneurons on the other hand represent
a minority (∼20%) of the entire neocortical neuronal popula-
tion (Whittington and Traub, 2003; Wang et al., 2004; Hensch,
2005). GABAergic interneurons are highly heterogeneous and had
been overlooked for many years due to their vast complexities.
However, it is thought that they play a vital role in the func-
tion of the cerebral cortex. Interneurons provide inhibitory inputs
that shape the responses of pyramidal cells and prevent runaway
excitation. They regulate the timing and synchronization of pop-
ulation rhythms expressed as cortical oscillations (Haider et al.,
2006; Klausberger and Somogyi, 2008). Consequently, reduction
in tonic inhibition through interneuron hypoplasia in the cortex
has been implicated in major neurological and psychiatric illness,
including epilepsy, mental retardation, autism, and schizophre-
nia (Powell et al., 2003b; Lewis et al., 2005; Akbarian and Huang,
2006; Yizhar et al., 2011).
Interneurons exhibit a remarkable intrinsic ability to migrate
and therefore offer a potential neuronal source for cell-based ther-
apies for treating the above mentioned interneuron deficiencies.
Recently, several elegant works have shown that transplanting
fetal interneuron precursors can create a new critical period
of plasticity in the recipient brain and reduce seizures in ani-
mal models of epilepsy (Wichterle et al., 1999; Alvarez-Dolado
et al., 2006; Baraban et al., 2009). Interneuron transplants can
also reduce movement deficits in a rat model of Parkinson’s dis-
ease (Martinez-Cerdeno et al., 2010). When transplanted into
the spinal cord, interneurons also help decrease pain sensation
(Braz et al., 2012). Together, these proof of principal studies raise
hope for the possibility of using neuronal transplantation to treat
diseases like epilepsy and Parkinson’s.
In this review, we provide a brief overview of the develop-
ment and function of cortical interneurons. We then evaluate
the current progress of interneuron production from pluripotent
stem cells. Finally, we discuss the potential and the challenges of
exploiting stem cell technologies for modeling neurological and
neuropsychiatric disorders, drug discovery and cell therapy.
CLASSIFICATIONS OF CORTICAL INTERNEURONS
Cortical interneurons are cells that connect only with nearby neu-
rons, to distinguish them from “projection” neurons, whose axons
span to more distant regions of the brain. Interneurons typically
express the inhibitory neurotransmitter gamma-amino butyric
(GABA) and have aspiny dendrites (Markram et al., 2004).
Despite these common features, interneurons display huge diver-
sity in morphology, physiology, and marker expression. Here we
Frontiers in Cellular Neuroscience www.frontiersin.org March 2013 | Volume 7 | Article 10 | 1
CELLULAR NEUROSCIENCE
Arber and Li Stem cell-derived interneurons
provide a brief summary of the complex classification of cortical
interneurons. For a thorough evaluation of the subject, refer to
the excellent reviews by Ascoli et al. (2008) and Batista-Brito and
Fishell (2009).
Efforts to distinguish interneurons based on morphology have
led to complex conclusions. Classifications based on synaptic tar-
gets of interneurons, i.e., axon, soma, proximal dendrite, or distal
dendrite, provide a useful starting point (DeFelipe, 1997). This
classification defines the role of the interneuron in the micro-
circuit. Interneurons that form synapses on pyramidal cell axons
have the potential to eradicate action potential transmission; con-
veying power to this subtype after sensing the global excitatory
environment. This is in contrast to interneurons that contact
distal dendrites of pyramidal cells that may influence signal for-
mation in more subtle ways, e.g., necessitating summation of
input signals (Markram et al., 2004). Interneuron groups that
have dendritic connections are more numerous and diverse than
those on the soma and axons due to the intricacies involved in
these roles.
It should be noted that not all GABAergic neurons in the
cortex are local interneurons with short-range associations.
Approximately 0.5% of cortical GABAergic cells are “projection”
neurons with long-range axons. The function of these cells in
the mature cortex remains uncertain (Tamamaki and Tomioka,
2010).
The branching morphology of an interneuron and its cor-
tical layer position can enable classifications into interneuron
type. Some of these cells were first described by the monumen-
tal work by Cajal y Ramon over a century ago (DeFelipe, 2002;
Sotelo, 2003). The groups include large basket cells, small basket
cells, nest basket cells, chandelier cells, Martinotti cells, bitufted
cells, bipolar cells, and double bouquet cells. This information is
also relevant for the synaptic targets of the cells discussed above
(Ascoli et al., 2008).
Interneurons can be classified based on their electrophysio-
logical properties, explored in slice culture studies. Classes such
as fast-spiking, non-adapting non-fast-spiking, adapting, irreg-
ular spiking, intrinsic burst firing, and accelerating have been
described (Ascoli et al., 2008). It is important to note that the
morphology and electrophysiological properties of the cells do
not correlate directly, adding further complexity to the clas-
sification problem. In an elegant study, Toledo-Rodriguez and
colleagues performed electrophysiological investigations followed
by single cell expression analysis (Toledo-Rodriguez et al., 2004).
Interestingly, they found individual genes that code ion chan-
nels which are predictive of electrophysiological class, for example
Kv1.1, HCN1, and Caα1A; potassium, sodium and calcium chan-
nel proteins respectively. This may become critical for grouping
interneurons into discrete subtypes.
Finally, interneurons can be distinguished based on expression
of calcium binding proteins and neuropeptides. It has become
convenient to distil the cells into three groups based on expression
of Parvalbumin, Somatostatin, and Calretinin, which largely do
not overlap (Kubota et al., 1994; Kawaguchi and Kubota, 1997).
There are a number of other markers that may be used to distin-
guish interneuron subclasses. These include Calbindin, a calcium
binding protein often used to describe cortical interneurons.
Calbindin is coexpressed with Parvalbumin or Somatostatin
in up to 80% of interneurons, making Calbindin an inap-
propriate marker (Kawaguchi and Kubota, 1997). Additionally,
Neuropeptide Y (NPY) and Vasoactive Intestinal Polypeptide
(VIP) are useful markers proteins, although these can display
some colabelling with Calretinin positive cells. All of these expres-
sion markers may have little functional relevance; however, it has
become clear from developmental biology that these classes orig-
inate in distinct locations, producing a useful fate map for devel-
opmental biologists. Again, there is no complete overlap between
morphology, physiology and these expression-based classes.
The extensive variability of interneurons and the complexity in
defining subclasses has led to the theory of an interneuron con-
tinuum, negating the presence of distinct subclasses (Parra et al.,
1998). The study by Toledo-Rodriguez, demonstrating cluster-
ing of subgroups dependent upon voltage gate channels, argues
against this continuum and encourages new techniques to clas-
sify subgroups. The field of stem cell biology utilizes information
from developmental biology to mirror development in vitro. For
this reason, it is convenient to employ developmental origin-
based division in this review, i.e., Parvalbumin, Somatostatin, and
Calretinin.
DEVELOPMENT OF CORTICAL INTERNEURONS
Although distributed dorsally in the cerebral cortex of the mature
brain, cortical interneurons are derived from neural precursors
generated in the ventral forebrain (telencephalon) and undergo
major tangential migration to their dorsal target tissues. Fate
mapping studies via isochronic, homotopic transplantation of
labeled ventral forebrain tissues in utero and in vitro have demon-
strated the vast migratory capacity of ventral progenitors and
their ability to form GABAergic interneuron subtypes (Anderson
et al., 1997; Lavdas et al., 1999; Nery et al., 2002).
The ventral telencephalon (also referred to as the subpallium)
is divided into three neurogenic domains, the lateral- medial- and
caudal-ganglionic eminences (LGE, MGE, and CGE respectively),
see Figure 1. The LGE is the birthplace of the striatal projection
neurons and a small population of olfactory bulb interneurons
that migrate rostrally (Waclaw et al., 2009). The MGE and the
CGE are the major sites of interneurogenesis, shown via the trans-
plantation of labeled tissue (Xu et al., 2004; Butt et al., 2005).
The CGE has been described as a caudal extension of the LGE
and the MGE and as such the three tissues share many com-
mon gene expression profiles (Flames et al., 2007). For example
Gsx2, Dlx2, and Mash1 are three transcription factors involved
in neurogenesis, patterning and migration and are expressed
throughout the ganglionic eminences. Despite this similarity,
there are genetic differences and precise expression domains that
are starting to be described (Flames et al., 2007; Willi-Monnerat
et al., 2008). Most importantly, the expression of Nkx2.1, a Shh
responsive gene (Xu et al., 2010), defines the MGE and the ven-
tral CGE, discerning these tissues from the LGE and the dorsal
CGE (Sussel et al., 1999).
Nkx2.1 expression is vital for MGE-based interneurogen-
esis, whereby its knockout reduced GABAergic populations
in the cortex by 50% (Sussel et al., 1999). Nkx2.1 has a
critical function to induce Lhx6, a gene which is required
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FIGURE 1 | Depiction of interneuron birth place and relevant gene
expression profile. Top shows ganglionic eminence distribution in a mouse
brain and the major interneurons migration streams, NB CGE is a caudal
extension of the more anterior tissues. Bottom shows anterior (left) and
posterior (right) coronal sections through the telencephalon of an E13 mouse.
Pertinent marker gene expression profiles are depicted of the proliferative
niches of the ganglionic eminences. Relative origin of interneuron subtypes
are shown in RED. Note the Shh expression domains and the reciprocal Gli3
expression. Abbreviations; LGE, lateral ganglionic eminence; MGE, medial
ganglionic eminence; CGE, caudal ganglionic eminence (v ventral and
d dorsal); OB, olfactory bulb; P/SP, pallial subpallial; POA, preoptic area;
PV, Parvalbumin; SST, Somatostatin; CR, Calretinin.
for specification and migration of MGE-derived GABAergic
interneurons (Du et al., 2008). After migrating to the cortex,
these Shh/Nkx2.1/Lhx6-patterned progenitors mature in situ into
Parvalbumin and Somatostatin expressing cortical interneurons.
Interneuron specification is origin specific (Butt et al., 2005) and
different regions of the MGE are thought to give rise to the
two cell types. Somatostatin-expressing interneurons originate in
the more lateral MGE, where Shh expression is higher, whereas
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Parvalbumin-expressing interneurons are derived from the more
ventral MGE domain (Wonders et al., 2008; Xu et al., 2010; Inan
et al., 2012). FGF signaling has also been implicated in ventral
forebrain development, as receptor knockout leads to aberrant
development (Storm et al., 2006). It should be noted that the
MGE gives rise to other cell types, including striatal interneurons,
cholinergic cells and glia, displaying distinct marker profiles.
Calretinin-expressing interneurons are unaffected by Nkx2.1
knockout (Sussel et al., 1999) and were subsequently demon-
strated to be derived in the dorsal CGE (dCGE) (Xu et al., 2004).
These interneurons are dependent upon early expression of Gsx2,
which is expressed higher in the dCGE and LGE compared with
the MGE. Recent work has proposed a novel role for Activin sig-
naling in inducing Gsx2 and Calretinin-expressing interneurons
in mouse and human embryonic stem cells (ESCs) (Cambray
et al., 2012). Additionally, NPY-expressing cells are specified in
the CGE in an undefined manner. Reports of the presence of
Parvalbumin and Somatostatin immunoreactivity in the CGE can
be attributed to progenitors migrating through the CGE from the
MGE. In addition to the cortex, CGE-derived progenitors con-
tribute strongly to interneuron populations in the hippocampus
(Nery et al., 2002).
Once specified in the early subpallium, the interneuron pro-
genitors migrate to their target tissues in the upper layers of the
cortex or the hippocampus (Miyoshi and Fishell, 2011). This
migration is dependent upon Dlx1/2 and Mash1 expression, as
progenitors accumulate in the ventral forebrain in mouse knock-
out models of these genes (Long et al., 2009) and cortical tissues
exhibit a 75% reduction in GABAergic cell numbers (Anderson
et al., 1997). The intricacies of the interneuron migration are not
well understood with a multitude of undefined factors directing
this complex process (Faux et al., 2012). However, it appears that
the cells do not follow corticofugal fibers toward target locations
(Nery et al., 2002). Many contact the cortical ventricular zone
together with newly-born cortical cells before migrating radially
to their target laminae (Nadarajah et al., 2002). Interestingly, the
different subtypes of cortical interneuron have differential tar-
get tissues, with respect to gross domains in the cortex as well
as layer preference (Nery et al., 2002). Temporal differences in
migration capacity have been described and cortical interneurons
are believed to migrate in an “inside-out” pattern, with deep layer
cells migrating earlier in development. This may have important
implications on transplantation and is discussed below.
These above observations of cortical interneuron development
have been based in rodent models. Recent data has reinforced the
conserved nature of interneuron birth and migration in human
development. For example, Calretinin progenitors have been
shown to originate in the human basal forebrain (Jakovcevski
et al., 2011; Zecevic et al., 2011) and loss of the ventral fore-
brain in the human fetus due to stroke leads to reduced numbers
of Somatostatin and NPY-expressing interneurons (Fertuzinhos
et al., 2009). These studies also indicated that there are criti-
cal differences between human and rodent development. Rodent
interneurons do not express Nkx2.1 during migration, whereas
human progenitor cells were shown to maintain NKX2.1 expres-
sion into the cortex (Rakic and Zecevic, 2003). Here there is
an additional mitotic event before the cells migrate radially to
their final positions (Letinic et al., 2002). This may add to the
complexity, size and additional cortical layering evident in the
higher mammalian cortex and is a feature repeated in simian
development (Petanjek et al., 2009). Therefore, generalization
and inferences for human development based on murine data
must be taken with caution; however, evidence does suggest
the presence of many parallels between the two developmental
systems.
Thus, interneurons are an extremely diverse population. Some
diversity can be attributed to differential developmental origins,
different morphogen responsiveness and fate determinant expres-
sion. This data becomes useful for stem cell biologists to parallel
development in vitro.
INTERNEURON DYSFUNCTION AND DISEASES
Deficiencies in cortical interneuron numbers may arise from
brain trauma, viral infections or gene mutations effecting func-
tion or migration; reviewed in Rossignol (2011). The “GABA
hypothesis” states that a reduced level of tonic inhibition in the
cortex or hippocampus leads to over-excitability and a spread
of seizure (Cossart et al., 2001). Therefore, interneuron dys-
function has been associated with epilepsy, autism (a disease
characterized by seizure) (Hussman, 2001), Tourette’s syndrome,
schizophrenia, and anxiety disorders (Lewis, 2000).
After initial epileptogenesis, there are a number of physiolog-
ical alterations in the local cellular environment that contribute
to chronic disease progression. This includes aberrant neurogen-
esis, alterations in cellular distributions, and gliogenesis (Maisano
et al., 2009). One example is the recruitment of astrocytes to the
focal site of seizure that express adenosine kinase; a molecule that
degrades the anticonvulsant adenosine and potentiates chronic
seizures (Gouder et al., 2004).
There are a number of animal models for seizure-based
disease. Overstimulation via the chemoconvulsant substances
kainic acid or pilocarpine leads to acute seizure and develop-
ment of spontaneous seizures over time (Maisano et al., 2009).
Additionally, there are a number of genetically altered paradigms
that lead to interneuron deficiencies, many of which are neona-
tal lethal. Loss-of-function mutations of Shh or Nkx2.1 lead to
improper patterning of the ventral telencephalon and a lack of
interneuron generation (Chiang et al., 1996; Sussel et al., 1999).
Dlx1/2 knockout mice exhibit a defect in migration (Long et al.,
2009). Mutations of the homeobox gene ARX in human sub-
jects have demonstrated an interneuron migration defect and
patients display autism and epilepsy. ARX is regulated by DLX2
(Friocourt and Parnavelas, 2010). Mutations in uPAR, the recep-
tor for hepatocyte growth factor/scatter factor (HGF/SF), lead
to aberrant migration of Parvalbumin cell precursors specifi-
cally and the adult mice display increased anxiety compared to
littermates (Powell et al., 2003a). Finally, DISC1 (Disrupted-in-
Schizophrenia-1) represents a factor crucial for neurite outgrowth
and mutations in this gene can lead to schizophrenia in patients
(Kamiya et al., 2005; Ayhan et al., 2011).
In addition to seizure-based diseases, interneuron deficien-
cies have been implicated in schizophrenia; whereby a reduc-
tion in GABAergic synapses by 40% have been noted in the
post mortem schizophrenic prefrontal cortex (Lewis, 2000).
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Also, similar studies revealed reductions in most interneuron
markers in developing schizophrenic brains (Fung et al., 2010).
Interneurons have also been implicated in bipolar disorder, anxi-
ety disorders and Tourette’s syndrome (Jetty et al., 2001; Kalanithi
et al., 2005).
PROOF-OF-CONCEPT TRANSPLANTATION STUDIES
One third of epileptics are resistant to current drug treatments
and all antiepileptics have major side-effects (Loring et al., 2007;
Loescher et al., 2008). Surgical resection of the seizure focal
point can be beneficial but depends on the function of the brain
location and is therefore only possible in a subset of patients.
Therefore, novel therapeutic avenues are of great interest.
The potential for cell replacement therapeutic strategies for
treating interneuronopathies has been demonstrated in the lit-
erature and is summarized in Table 1. The first critical evidence
that promoted ventral forebrain-derived GABAergic cells was the
extensive migrational capacity of grafted interneurons after corti-
cal transplantation. Compared with LGE and cortically-derived
cells that show little migration, MGE derivatives migrate sev-
eral millimeters into the cortex (Wichterle et al., 1999). These
grafted cells have the ability to differentiate into interneurons
that express the correct markers, display characteristic physiolog-
ical features and integrate to provide inhibitory synaptic activity
(Alvarez-Dolado et al., 2006).
To investigate the potential of MGE-derived tissue to reverse
the diseased state, several studies have grafted fetal GABAergic
precursors into seizure model rodents. TypicallyMGE tissue from
E12.5–E14.5 mouse embryos (a time of major interneurogen-
esis in the mouse embryo) is dissociated and grafted into the
cortex (Xu et al., 2004). Baraban and colleagues demonstrated
that wild-type MGE-tissue grafted into the cortex of a Shaker-like
model of epilepsy (Kv1.1 knockoutmice) reduced the number and
duration of spontaneous seizures 30 days after transplantation
(Baraban et al., 2009).
The convulsive drug 4-aminopyridine (4-AP) is able to elicit
focal ictal-like events due to evoked neurotransmitter release.
Transplantation of E13.5 MGE cells are able to reduce the power
of the seizure 2.5–8 weeks post grafting (De la Cruz et al., 2011).
Interestingly, there was no relationship between graft effectiveness
and the number of MGE cells transplanted in this study.
Maximum electroconvulsive shock (MES)-induced epilep-
tic rodents have unaltered brain circuitry and so represent a
good model for chronic epilepsy. Rodents that received MGE
grafts in this model displayed a higher threshold to MES and a
lower mortality rate 2 months after grafting (Calcagnotto et al.,
2010a). Kainic acid-induced mouse models of chronic temporal
lobe epilepsy have been grafted with neural stem cells (NSCs)
expanded from E14 MGE tissues. Cells were grown in vitro using
EGF and FGF2 before being transplanted into rodent hippocam-
pus. The authors observed reduced frequency and severity of
seizures three months after transplantation, although cognitive
function (learning and memory) was not improved (Waldau
et al., 2010).
Injection of neurotoxin-conjugated Substance P (SSP-Sap),
that targets interneurons expressing the Substance P recep-
tor NK-1, has been used to selectively degrade interneu-
rons in the hippocampus (Martin and Sloviter, 2001). This
leads to reduced numbers of Somatostatin-, NPY- and NK-1-
expressing interneurons while the Calretinin and Parvalbumin
Table 1 | Transplantation of fetal-derived interneuron precursors.
Author Transplanted
tissue
Model Results
Baraban et al., 2009 E13.5 MGE Kv1.1 mutant mouse
Epilepsy model
GABAergic cells, increased GABAergic synapses. PV, SST, CR,
NPY Reduced episodes of seizure and duration 30 days
post-transplant
Calcagnotto et al., 2010b E12.5 MGE tissue SSP-Sap injected cortex Restored inhibition within cortex
Calcagnotto et al., 2010a MGE tissue Maximum electroconvulsive
shock model
Reduced seizure and decreased mortality PV, CR, NPY,
2 months after graft
De la Cruz et al., 2011 E13.5 MGE tissue
(ventral vs. dorsal)
Ictal discharges induced by
4-AP
Attenuated propagation of ictal discharges. 2.5–8 weeks after
transplant
Waldau et al., 2010 NSCs expanded
from E14 MGE
Kainic acid induced epilepsy Reduced frequency, duration and severity of seizure 3 months
after graft
Zipancic et al., 2010 E12.5 MGE SSP-Sap Repopulate hippocampus after 2 months, Reduced seizure
severity and mortality
Alvarez-Dolado et al., 2006 E12.5–E13.5 Evident interneuron morphology, expression, physiology.
Increased GABAergic synaptic activity on pyramidal neurons Up
to after 60 days
Details of tissue source and preparation, animal model and a summary of the results are described. Abbreviations: MGE, medial ganglionic eminence; NSC, neural
stem cell; 4-AP 4-aminopyridine; PV, Parvalbumin; SST, Somatostatin; CR, calretinin; NPY, neuropeptide Y.
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subpopulations unaffected or slightly reduced, respectively. The
group of Alvarez-Dolado demonstrated that E12.5 MGE-derived
cells were able to repopulate the SSP-Sap treated hippocam-
pus two months after grafting and increase inhibitory synaptic
events on hippocampal pyramidal cells. This was associated with
reduced mortality rate and seizure severity (Calcagnotto et al.,
2010b; Zipancic et al., 2010).
Other cell sources have been shown to have potential ben-
efit in models of interneuron disease. Firstly, NSCs derived
from 15 week human fetal tissue were injected into the rat
tail vein of a pilocarpine model. GAD67 expressing cells were
detected in the recipient hippocampus which was accompanied
by reduced pyramidal cell excitability (Chu et al., 2004). Neonatal
hippocampal-derived NSCs have displayed an ability to differen-
tiate into neurons and glia (Shetty et al., 2008). However, these
cells have limited GABAergic potential, especially compared to
ventral-forebrain-derived NSCs (He et al., 2001).
Other strategies tested to reverse epilepsy include transplant-
ing cells constitutively expressing GABA to replace the inhibitory
deficiency (Gernert et al., 2002; Thompson and Suchomelova,
2004; Thompson, 2005), or to inhibit the action of adenosine
kinase which degrades the anticonvulsive drug adenosine in the
injured brain (Huber et al., 2001; Guttinger et al., 2005; Ren
et al., 2007; Li et al., 2008). These strategies showed limited
benefits as the cells do not integrate into the cortical circuits
and are not activity dependent; features that may be required to
reduce seizures. Finally, ventral telencephalic tissue grafted into
the ventral midbrain [substantia nigra (SN) pars reticulata] also
demonstrated a reduction in seizure propagation (Loscher et al.,
1998). This tissue has been implicated seizure propagation in
various epilepsy models.
Although interneuron dysfunction has been implicated in
neuropsychiatric diseased states such as anxiety disorders and
attention deficit disorder, the potential use of cellular replacement
therapy has not been addressed (Jetty et al., 2001; Boy et al., 2011;
Edden et al., 2012).
INTERNEURONS FROM PLURIPOTENT STEM CELLS
Human ESCs and iPSCs can be differentiated into any somatic
cell type and offer an unlimited supply of medically important
cells (Thomson et al., 1998). These cells may be employed to
elucidate disease etiology and develop novel therapies, includ-
ing putative cell replacement strategies. The goal of stem cell
research is to understand lineage and cell fate specification in
normal development in order to produce disease-relevant and
functional post mitotic cells. Several lines of study have employed
morphogenic conditions capable of directing mouse and human
ESCs toward a ventral telencephalic fate. However, when com-
pared to some other neuronal cells, such as midbrain dopamine
neurons (Jaeger et al., 2011; Kriks et al., 2011), relatively little
is known on how to control human pluripotent stem cell differ-
entiation into distinct cortical interneuron subtypes (for current
progress see Table 2).
Ruschenschmidt et al. described the first ESC-derived neurons
to be grafted into pilocarpine-treated chronically epileptic rats
(Ruschenschmidt et al., 2005). Mouse ESCs were differentiated
in aggregates termed embryoid bodies (EBs) in a neural albeit
undirected manner. The resultant neurons, presumably of mixed
identity, were transplanted into the hippocampus of epileptic rats.
The grafts exhibited neuronal properties but did not produce any
functional recovery and there was no extensive migration into the
host brain, features that might be expected with interneuron-rich
grafts (Wichterle et al., 1999).
Subsequent studies attempted a more directed differentia-
tion scheme, i.e., toward a telencephalic progenitor fate. These
studies demonstrate that, in serum-free conditions, neural pre-
cursors with a rostral identity can be generated from both human
and mouse ESCs using an EB differentiation method (Watanabe
et al., 2005, 2007). Telencephalic progenitors can also be gen-
erated using adherent monolayer-based differentiation protocols
together with SMAD inhibitors in a manner parallel to the
Anterior Neuroectoderm Ridge instructed development in vivo
(Ying et al., 2003; Chambers et al., 2009).
Dorsoventral patterning of ESC-derived forebrain precursors
by morphogenic gradients appears to mimic that observed during
normal development. Shh is a strong ventralizing factor through-
out the neural tube (Ericson et al., 1995) and specifies MGE
identity through induction ofNkx2.1. Studies that applied graded
dosage of Shh to telencephalic progenitor cells showed that a
high concentration of Shh (or Shh agonists) is able to induce
Nkx2.1 and results in characteristic interneuron marker expres-
sion in ESC-derived neural cultures (Watanabe et al., 2005, 2007;
Gaspard et al., 2008; Li et al., 2009; Danjo et al., 2011; Ma et al.,
2012). All these studies demonstrated the instructive capabilities
of Shh to promoteMGE-like identity at high dose and an LGE-like
fate at lower doses. Cortical fate was induced when Shh signaling
was antagonized. It should be noted that Nkx2.1 is also expressed
in the ventral diencephalon and so is not specific to MGE-derived
interneuron progenitors (Ohyama et al., 2005).
A number of studies have investigated the functionality of
in vitro derived interneurons and performed grafting studies of
ESC-derived cultures into rodent model organisms. Maroof et al.
utilized an EB based differentiation scheme followed by Shh
treatment to produce ventral telencephalic-like cells from mouse
ESCs (Maroof et al., 2010). Using an Lhx6-reporter that specifi-
cally marks the migrating MGE-derivatives, the authors purified
putative interneurons by FACS and grafted the GFP expressing
cells into the adult mouse cortex. They observed extensive cellu-
lar migration and survival. Graft-derived cells exhibited classical
interneuron marker expression (predominantly Parvalbumin and
Somatostatin) and electrophysiological properties nine months
post-transplantation.
Maisano et al. subsequently produced interneuron-like cells
from mouse ESCs via adherent monolayer differentiation
(Maisano et al., 2012). To promote ventral telencephalic differ-
entiation, the authors used a Shh agonist and witnessed faithful
differentiation in vitro. Following transplantation into the hip-
pocampus of a pilocarpine-based mouse model for temporal
lobe epilepsy, the neural precursors reliably formed GABAergic
neurons, replacing those lost in this model. These cells were
physiologically indicative of GABAergic cells and expressed
Parvalbumin, Calbindin, and Calretinin but not Somatostatin.
This may be explained by the sensitivity of Somatostatin-
expressing cells to pilocarpine treatment. Unfortunately, the
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Table 2 | Progress in ESC-derived cortical interneurons and their transplantation in vivo.
Author Species Differentiation Strategy Growth factors In vitro In vivo
Goulburn et al., 2011 Human Spin EBs NKX2.1 reporter FGF2 and RA Appropriate progenitor
markers GABAergic
neurons, PV, SST
expression.
Electrophysiology and
migration
Migration capacity and
expressed GABA
Cambray et al., 2012 Human and
mouse
Adherent
monolayer
Activin CGE markers, CR neurons Bipolar orientated cells
in cortex
Maisano et al., 2012 Mouse Adherent
monolayer
Sox1 Reporter HH agonist CR and CB expression TLE model, PV, CR,
CB, small effect on
mossy fiber sprouting,
electrophysiology
Maroof et al., 2010 Mouse EBs Lxh6 reporter SHH, IGF, FGF2 Interneuron precursor
expression,
Migration in cortex, PV,
SST Electrophysiology,
9 month survival.
Danjo et al., 2011 Mouse Spin EBs Foxg1 reporter SHH, FGF8 vs.
FGF15/19
Nkx2.1 expression, PV,
SST, NPY, CR
Slice culture migration
Ma et al., 2012 Human EBs Shh Nkx2.1, Gsx2
Li et al., 2009 Human EBs Gli3 RNAi Shh, Dkk1 Nkx2.1, Gsh2, Isl1,
GAD67
Watanabe et al., 2007 Human EBs Shh Nkx2.1
Watanabe et al., 2005 Mouse EBs Dkk1, LeftyA, Shh Nkx2.1, Gsx2, Isl1
Gaspard et al., 2008 Mouse Adherent
monolayer
Endogenous Shh
in basal conditions
Nkx2.1, multipolar cells,
inhibitory synaptic activity
Details of species of ESCs used, differentiation technique and precise strategies and the results both in vivo and in vitro are given. Abbreviations: EB, embryoid
body; HH, hedgehog; PV, Parvalbumin; SST, Somatostatin; CGE, caudal ganglionic eminence; CR, calretinin; CB, Calbindin; NPY, neuropeptide Y; TLE, temporal lobe
epilepsy.
authors did not observe a statistical reduction in mossy fiber
sprouting, a characteristic trait of epilepsy.
Goulburn et al. utilized an NKX2.1-GFP human ESC reporter
cell line to purify ventral telencephalic-like cells (Goulburn et al.,
2011). The group used an EB-based neural induction protocol
with FGF2 and retinoid acid (RA) treatment to promote NKX2.1
promoter-driven GFP expression. Although the use of RA is con-
tentious, the RA signaling pathway has been shown to be relevant
for early forebrain development (Schneider et al., 2001; Stavridis
et al., 2010; Chatzi et al., 2011). Sorted NKX2.1-GFP+ cells gave
rise to GABAergic and Somatostatin-expressing neurons in vitro
that displayed migration capacity both in vitro and in vivo. These
sorted cells also expressed diencephalic marker genes; a second
region that is dependent on NKX2.1 expression. Therefore, all the
evidence thus far indicates that the MGE is patterned by Shh and
that Shh can induce ESCs to generate at least some subtypes of
MGE-derived interneurons.
A recent study described the generation of Calretinin-
expressing cortical interneurons from mouse and human
ESCs/iPSCs (Cambray et al., 2012). During development, the
majority of Calretinin interneurons are believed to be generated
in the dorsal CGE, which appears to be non-responsive to Shh
[see Figure 1 (Xu et al., 2010)]. Using an adherent monolayer dif-
ferentiation strategy, Cambray et al. reported that signaling via
Activin induces the expression of genes that are associated with
the CGE and promote the generation of Calretinin-expressing
interneurons with minimal generation of MGE-derived interneu-
ron subtypes (Cambray et al., 2012). Following transplantation,
these neurons exhibited bipolar morphology in the adult rodent
cortex. Members of fibroblast growth factors (FGFs) have also
been reported to specify either an MGE or CGE-like fate (FGF8
vs. FGF15/19 respectively) as well as their neuronal derivatives
(Danjo et al., 2011).
Together these studies provide a strong argument for the
potential benefit of investigating further ESC-derived interneu-
rons for the treatment of interneuronopathies. It is clear that the
vast intricacies of cell specification require a great deal of work
to improve our understanding of the developmental events, for
example genome-wide investigations. As well as the patterning
of interneuron precursors, aspects such as developmental timing
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and transplantation site may have a huge impact on the final
phenotype of a transplanted cell through exogenous signaling
environments. The safety of ESC-derived cells must be care-
fully considered before transplantation; namely proliferation of
undifferentiated cells, side-effects of cell heterogeneity and com-
plications associated with surgery. These factors will need to be
investigated fully to maximize the potential of this technology.
FUTURE PERSPECTIVES
The power of ESCs in generating subpallial-derived interneu-
rons is starting to be unlocked. Future work is needed to expand
the repertoire of interneuron subtypes generated from hESCs
and iPSCs. Precise temporal control of developmental signal-
ing pathways may be critical to direct preferential production of
individual interneuron subtypes. For example, within the MGE,
progenitors respond to higher doses of Shh preferentially to give
rise to Somatostatin neurons while the progenitors that experi-
ence lower level of Shh signaling differentiate into Parvalbumin-
expressing neurons (Wonders et al., 2008; Xu et al., 2010; Inan
et al., 2012). It would be interesting to see how these develop-
mental findings translate to neuronal subtype specification in
stem cell systems. The development of novel interneuron dif-
ferentiation protocols would benefit from better characterization
of interneuron diversity in model organisms that establish links
between cellular morphology, neurochemical phenotypes, synap-
tic connection types, and electrophysiological properties of the
interneurons.
Neuropsychiatric disorders present a major burden to modern
society. The major limitation for the development of new treat-
ments has been the lack of defined etiology and limited knowl-
edge of the disease pathophysiology (Lewis and Gonzalez-Burgos,
2006). Studies of these diseases rely on imaging techniques and
post-mortem analysis of patients’ brains. It is generally recog-
nized that neuropsychiatric diseases are developmental disorders
due to aberrant neuronal wiring. In this regard, human ESCs
provide a robust in vitro model to gain insight into human cor-
tical development. Much of our knowledge on the human brain
and psychiatric diseases stems from rodent models. However,
the human cortex is significantly larger than the rodent’s with
extra cortical germinal layers (Molnar et al., 2011). Particularly
relevant to interneuron disease is the fact that the human and
rodent brains differ in the ratio of inhibitory/excitatory neurons.
This difference may impact on interneuron regulated network
function and hence the extent to which rodent models can mimic
human conditions. Furthermore, the genetic variants identified
in psychiatric patients often involve long range genomic dupli-
cations or deletions spanning multiple genes. Such complex
genetic variants can be difficult to model in an animal model.
Patient-derived iPSCs offer unprecedented opportunity to gener-
ate human neurons with identical genetic information to that of
patients to unravel the cellular defects and underlying molecular
mechanisms caused by disease gene mutations. Therefore, hiPSCs
offers a tractable alternative to rodent models.
The success of fetal tissue-based grafts has paved the way
for stem cell-based interneuron replacement strategies. However,
stem cell-derived interneurons have so far not been shown to
produce a functional effect on disease models (Maroof et al.,
2010; Goulburn et al., 2011; Cambray et al., 2012; Maisano et al.,
2012). Furthermore, certain hurdles should be kept in mind with
regard to interneuron transplantation therapy. Firstly, a propor-
tion of pharmacoresistant epileptic patients do not respond to
exogenous GABA administration as a treatment. Would grafted
GABAergic cells have a beneficial effect in this paradigm? Cortical
interneurons also have much interneuron-to-interneuron synap-
tic contact. For this reason, the subtype of grafted neurons must
be carefully monitored to prevent altered activity of existing
inhibitory cells within the disease setting. As discussed, the devel-
opmental timing and the transplantation site may have extrinsic
effects on a transplanted cell’s fate and so must be appreci-
ated prior to transplant optimization. Finally, as with all stem
cell-derived cell therapy postulations, a number of caveats may
limit the safety of such an approach. For example, contaminat-
ing undifferentiated cells from the in vitro differentiation process
may lead to cellular overgrowths and teratomas as well as other,
off-target cells leading to adverse effects.
Nevertheless, the field of cortical interneuron dysfunction is
set to welcome ESC based strategies that will enable a big step
toward disease modeling and cell-based therapies for treating
common neurological disorders.
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